Ulotaront

3 trials

Filter these 3 trials by condition, phase, country and more.

Open in Search →

3 Registered trials

0 Recruiting

3 Completed trials

3 Sponsors

11 Countries

Phase II/III

Phase II/III: 3

Indications tested

Generalised anxiety disorder 1

Sponsors using this IMP

Otsuka Pharmaceutical Development & Commercialization Inc. 1 Otsuka Pharmaceutical Development And Commercialization Inc. 1 Sumitomo Pharma Co. Ltd. 1

All trials

3 total

A Clinical Study that will measure how well SEP-363856 works and how safe it is in adults with Generalized Anxiety Disorder Ended

2022-502077-42-00 Phase II/III 6 countries Otsuka Pharmaceutical Development & Commercialization Inc.
Protocol Lay Person Short Title: A Trial of the Safety and Efficacy of Flexible Doses of SEP-363856 as Adjunctive Therapy in the Treatment o… Ended

2022-500538-27-00 Phase II/III 6 countries Otsuka Pharmaceutical Development And Commercialization Inc.
A Clinical Trial to Evaluate the Efficacy and Safety of SEP-363856 in Acutely Psychotic People With Schizophrenia, Followed by an Open-label… Ended

2022-503006-20-00 Phase II/III 1 country Sumitomo Pharma Co. Ltd.

Showing 1–3 of 3 trials

← All drugs A–Z